Literature DB >> 17721792

Cancer-associated retinopathy (CAR) with electronegative ERG: a case report.

Griet Goetgebuer1, Anna-Maria Kestelyn-Stevens, Jean-Jacques De Laey, Philippe Kestelyn, Bart P Leroy.   

Abstract

Cancer-associated retinopathy (CAR) should be suspected in patients who present with visual symptoms such as rapid unexplained visual loss and seeing shimmering lights, with an abnormal ERG. Electronegative ERG responses are not exclusive to melanoma-associated retinopathy (MAR) but may be seen in CAR as well. We describe a patient with CAR who presented with an electronegative ERG. A 67-year old woman, who presented with complaints of seeing shimmering lights, underwent an extensive ophthalmological and electrophysiological examination. Best-corrected visual acuity was 7/10 in the right and 9/10 in the left eye. Goldmann visual fields showed relative central scotomata and concentric narrowing. Slit-lamp and fundus examination were normal as was fluorescein angiography. Rod-specific ERG responses were severely reduced, with electronegative maximal combined rod-cone responses and delayed cone-responses with normal amplitudes. Melanoma-associated retinopathy was suspected. Extensive dermatological and internal evaluation eventually revealed an oat-cell carcinoma in the right lung. The patient died of pneumonia 2 years after presentation.

Entities:  

Mesh:

Year:  2007        PMID: 17721792     DOI: 10.1007/s10633-007-9074-9

Source DB:  PubMed          Journal:  Doc Ophthalmol        ISSN: 0012-4486            Impact factor:   2.379


  26 in total

1.  Fluorescein angiographic findings in a case of cancer-associated retinopathy.

Authors:  N Masaoka; Y Emoto; A Sasaoka; A Fukushima; H Ueno; H Ohguro
Journal:  Retina       Date:  1999       Impact factor: 4.256

Review 2.  Retinopathies associated with antiretinal antibodies.

Authors:  J J Hooks; M O Tso; B Detrick
Journal:  Clin Diagn Lab Immunol       Date:  2001-09

3.  Nature of the cone ON-pathway dysfunction in melanoma-associated retinopathy.

Authors:  Kenneth R Alexander; Claire S Barnes; Gerald A Fishman; Ann H Milam
Journal:  Invest Ophthalmol Vis Sci       Date:  2002-04       Impact factor: 4.799

4.  The incidence of negative ERG in clinical practice.

Authors:  A H Koh; C R Hogg; G E Holder
Journal:  Doc Ophthalmol       Date:  2001-01       Impact factor: 2.379

Review 5.  Clinical and immunologic characteristics of melanoma-associated retinopathy syndrome: eleven new cases and a review of 51 previously published cases.

Authors:  J L Keltner; C E Thirkill; P T Yip
Journal:  J Neuroophthalmol       Date:  2001-09       Impact factor: 3.042

6.  Clinical and electrophysiologic characterization of paraneoplastic and autoimmune retinopathies associated with antienolase antibodies.

Authors:  Richard G Weleber; Robert C Watzke; William T Shults; Karmen M Trzupek; John R Heckenlively; Robert A Egan; Grazyna Adamus
Journal:  Am J Ophthalmol       Date:  2005-05       Impact factor: 5.258

Review 7.  Melanoma-associated retinopathy: does autoimmunity prolong survival?

Authors:  C Chan; J O'Day
Journal:  Clin Exp Ophthalmol       Date:  2001-08       Impact factor: 4.207

Review 8.  Electrophysiology in the investigation of acquired retinal disorders.

Authors:  H P Scholl; E Zrenner
Journal:  Surv Ophthalmol       Date:  2000 Jul-Aug       Impact factor: 6.048

Review 9.  Paraneoplastic retinopathies and optic neuropathies.

Authors:  Jane W Chan
Journal:  Surv Ophthalmol       Date:  2003 Jan-Feb       Impact factor: 6.048

10.  Clinical and immunologic aspects of cancer-associated retinopathy.

Authors:  Hiroshi Ohguro; Yumiko Yokoi; Ikuyo Ohguro; Kazuhisa Mamiya; Futoshi Ishikawa; Hitoshi Yamazaki; Tomomi Metoki; Yoshiko Takano; Tadashi Ito; Mitsuru Nakazawa
Journal:  Am J Ophthalmol       Date:  2004-06       Impact factor: 5.258

View more
  10 in total

1.  Case of paraneoplastic retinopathy with retinal ON-bipolar cell dysfunction and subsequent resolution of ERGs.

Authors:  Shinji Ueno; Ayami Nakanishi; Kayo Nishi; Shiro Suzuki; Hiroko Terasaki
Journal:  Doc Ophthalmol       Date:  2014-11-13       Impact factor: 2.379

2.  Cancer-associated retinopathy presenting as retinal vasculitis with a negative ERG suggestive of on-bipolar cell pathway dysfunction.

Authors:  Anastasios Anastasakis; Andrew D Dick; Erika M Damato; Paul G Spry; Mohamed A Majid
Journal:  Doc Ophthalmol       Date:  2011-06-15       Impact factor: 2.379

3.  Unilateral negative electroretinogram presenting as photophobia.

Authors:  Ai Kido; Ken Ogino; Yozo Miyake; Kazuo Yanagida; Takanobu Kikuchi; Nagahisa Yoshimura
Journal:  Doc Ophthalmol       Date:  2016-05-31       Impact factor: 2.379

4.  Negative electroretinograms in the pediatric and adult population.

Authors:  Johnstone M Kim; John F Payne; Jiong Yan; Claire S Barnes
Journal:  Doc Ophthalmol       Date:  2012-01-13       Impact factor: 2.379

5.  Identification of autoantibodies against TRPM1 in patients with paraneoplastic retinopathy associated with ON bipolar cell dysfunction.

Authors:  Mineo Kondo; Rikako Sanuki; Shinji Ueno; Yuji Nishizawa; Naozumi Hashimoto; Hiroshi Ohguro; Shuichi Yamamoto; Shigeki Machida; Hiroko Terasaki; Grazyna Adamus; Takahisa Furukawa
Journal:  PLoS One       Date:  2011-05-17       Impact factor: 3.240

6.  Acute progressive paravascular placoid neuroretinopathy with negative-type electroretinography in paraneoplastic retinopathy.

Authors:  Fred K Chen; Avenell L Chew; Dan Zhang; Shang-Chih Chen; Enid Chelva; Erandi Chandrasekera; Eleanor M H Koay; John Forrester; Samuel McLenachan
Journal:  Doc Ophthalmol       Date:  2017-04-05       Impact factor: 2.379

7.  Identification and characterization of novel TRPM1 autoantibodies from serum of patients with melanoma-associated retinopathy.

Authors:  Juliette Varin; Margaret M Reynolds; Nassima Bouzidi; Sarah Tick; Juliette Wohlschlegel; Ondine Becquart; Christelle Michiels; Olivier Dereure; Robert M Duvoisin; Catherine W Morgans; José-Alain Sahel; Quentin Samaran; Bernard Guillot; José S Pulido; Isabelle Audo; Christina Zeitz
Journal:  PLoS One       Date:  2020-04-23       Impact factor: 3.240

8.  Immunotherapy-induced retinopathy mimicking cancer associated retinopathy.

Authors:  Hashem Ghoraba; Christopher Or; Irmak Karaca; Kapil Mishra; Amir Akhavanrezayat; Sungwho Park; Ngoc Than; Loh-Shan Leung; Steven Sanislo; Quan Dong Nguyen
Journal:  Am J Ophthalmol Case Rep       Date:  2022-03-01

9.  Degeneration of retinal on bipolar cells induced by serum including autoantibody against TRPM1 in mouse model of paraneoplastic retinopathy.

Authors:  Shinji Ueno; Koji M Nishiguchi; Hidetoshi Tanioka; Atsushi Enomoto; Takashi Yamanouchi; Mineo Kondo; Testuhiro R Yasuma; Shunsuke Yasuda; Noriyuki Kuno; Masahide Takahashi; Hiroko Terasaki
Journal:  PLoS One       Date:  2013-11-25       Impact factor: 3.240

10.  Non-Paraneoplastic Autoimmune Retinopathy: The First Case Report in Korea.

Authors:  Eun Young Choi; Min Kim; Grazyna Adamus; Hyoung Jun Koh; Sung Chul Lee
Journal:  Yonsei Med J       Date:  2016-03       Impact factor: 2.759

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.